絞り込み

16643

広告

Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene.

著者 Gustavsson N , Marote A , Pomeshchik Y , Russ K , Azevedo C , Chumarina M , Goldwurm S , Collin A , Pinto L , Salgado AJ , Klementieva O , Roybon L , Savchenko E
Stem Cell Res.2018 Dec 26 ; 34():101373.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (56view , 0users)

Full Text Sources

Research Materials

ULUNDi007-A (CVCL_UL02)

Mutations in the glucocerebrosidase (GBA) gene have been associated with the development of Parkinson's disease (PD). An induced pluripotent stem cell (iPSC) line was generated from a 60-year old patient diagnosed with PD and carrying a new mutation variant p.R301C in GBA. Using non-integrating Sendai virus-based technology, we utilized OCT3/4, SOX2, c-MYC and KLF4 transcription factors to reprogram skin fibroblasts into iPSCs. The generated iPSC line retained the mutation, displayed expression of common pluripotency markers, differentiated into the three germ layers, and exhibited normal karyotype. The iPSC line can be further used for studying PD pathogenesis.
PMID: 30640063 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード